A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
Imugene Limited
Imugene Limited
Suzhou Genhouse Bio Co., Ltd.
The First Affiliated Hospital of Dalian Medical University
Institut Paoli-Calmettes
Centre Hospitalier Universitaire Vaudois
Zhejiang University
Palobiofarma SL
Aurigene Discovery Technologies Limited
Fudan University
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Vastra Gotaland Region
Karolinska University Hospital
Multitude Therapeutics Inc.
Centre Georges Francois Leclerc
Lebanese University
Avistone Biotechnology Co., Ltd.
Shanghai Henlius Biotech
Biocad
Second Affiliated Hospital of Guangzhou Medical University
Shandong Cancer Hospital and Institute
BGI, China
NovalGen Ltd.
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Fox Chase Cancer Center
University of Kansas Medical Center
Guangzhou Institute of Respiratory Disease
BGI, China
Qilu Pharmaceutical Co., Ltd.
Qianfoshan Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Provectus Pharmaceuticals
Wellmarker Bio
Revolution Medicines, Inc.
Tianjin Medical University Cancer Institute and Hospital
Imperial College London
The First Affiliated Hospital of Bengbu Medical University
Betta Pharmaceuticals Co., Ltd.
University of Tennessee
Infinity Pharmaceuticals, Inc.
Changchun GeneScience Pharmaceutical Co., Ltd.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Betta Pharmaceuticals Co., Ltd.
Shanghai Zhongshan Hospital
Guangzhou Institute of Respiratory Disease
Tang-Du Hospital
Olivia Newton-John Cancer Research Institute
Jiangsu Simcere Pharmaceutical Co., Ltd.
Emory University
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.